Belite Bio (BLTE) Other Non Operating Income (2024 - 2025)
Belite Bio (BLTE) posted quarterly Other Non Operating Income of -$302000.0 for Q4 2025, down 322.06% year-over-year from $136000.0 in Q4 2024, and down 322.06% on a QoQ basis from $136000.0 in Q4 2024.
Belite Bio (BLTE) Other Non Operating Income (2024 - 2025) Analysis & Trends
Belite Bio (BLTE) has reported Other Non Operating Income for 2 consecutive years, with -$302000.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - |
| 10 | Belite Bio | 96.77 Mn | 96.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -302,000.00 |
| Dec 31, 2024 | 136,000.00 |